<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03084549</url>
  </required_header>
  <id_info>
    <org_study_id>CHD065-16</org_study_id>
    <nct_id>NCT03084549</nct_id>
  </id_info>
  <brief_title>Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain</brief_title>
  <acronym>ROPISIO</acronym>
  <official_title>Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain: a Randomized, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Episiotomy is a common obstetric gesture (20 to 30% of deliveries by the low route). In
      postpartum, perineal pains associated with episiotomy are common, about 70% on D7 and
      persistent 13% at 5 months. Most studies of obstetrical analgesia have focussed on pain
      during labor or following a caesarean section. The perineal pain associated with the
      realization of an episiotomy has been much less studied and often undervalued.

      Local ropivacaine has shown its effectiveness in the reduction of postoperative pain in many
      indications (wall surgery, hemorrhoidectomy, infiltration of trocar scars during
      laparoscopy). This product has the advantage of being well tolerated, easy access and
      administration. Three recent studies compared the post-episiotomy analgesic efficacy of local
      ropivacaine versus lidocaine versus placebo and lidocaine versus no infiltration. Two of
      these studies showed statistically significant results. However, they focused on the results
      at 24 and 48 hours and did not evaluate the analgesic efficacy in the medium and long term.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2017</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the analgesic efficacy of ropivacaine 75 mg infusion versus placebo (physiological saline) in patients with right mid-lateral episiotomy during postpartum D7 delivery.</measure>
    <time_frame>7 days after episiotomy</time_frame>
    <description>Digital pain scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">272</enrollment>
  <condition>Episiotomy</condition>
  <arm_group>
    <arm_group_label>Ropivacaïne</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administration of Ropivacaïne</intervention_name>
    <description>Administration of Ropivacaïne in the margins of the episiotomy</description>
    <arm_group_label>Ropivacaïne</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administration of placebo</intervention_name>
    <description>Administration of placebo in the margins of the episiotomy</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major Patient (≥ 18 years)

          -  Term ≥ 37 weeks of amenorrhea

          -  Right medio-lateral episiotomy performed for medical need

          -  Delivery of a single fetus in a cephalic presentation with or without instrumental
             extraction

          -  Delivery under epidural anesthesia

          -  Patient to be monitored over 6 months of study

          -  Patient in ability to understand protocol

          -  Patient having given consent and signed informed consent

          -  Patient with social coverage

        Exclusion Criteria:

          -  Hypersensitivity or known allergy to Ropivacaine or to other amide-linked local
             anesthetics or to any of the excipients

          -  General contraindication specific to local anesthesia, irrespective of the local
             anesthetic used

          -  Contraindication for Ropivacaine- Obstetric paracervical anesthesia

          -  Hypovolemia

          -  Weight &lt;50 kg

          -  Contra-indication or refusal of the epidural

          -  Poor understanding of the French language

          -  Substance addiction.

          -  Chronic pain syndrome.

          -  Severe hepatic or renal impairment.

          -  Acute porphyria.

          -  Caesarean section programmed.

          -  Tear of the 3rd degree according to the associated French classification.

          -  Refusal to participate in the study

          -  Patient under tutelage, curatorship, or deprived of liberty
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume DUCARME</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHD Vendée</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucie AUZANNEAU</last_name>
    <phone>0251446380</phone>
    <email>lucie.auzanneau@chd-vendee.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Departemental Vendee</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Guillaume DUCARME</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Norbert WINER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2017</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

